Valmet Advantage tissue line at Hengan's mill in China
March 03, 2018 - China
Valmet and Hengan have joined forces to start a Valmet Advantage DCT 200 tissue line at Hengan's mill in Weifang, China. PM21 is the third of four Advantage DCT 200 lines recently ordered by Hengan. When the startup of PM22 happens at the mill in Weifang later this year, Hengan will have a total of eight Valmet supplied tissue production lines in operation.
The other two Advantage DCT 200 machines were started in Wuhu, China, with excellent results in 2016. All three startups have been well coordinated and performed in record time, which creates a great outlook for the upcoming PM22 premiere.
The investments support Hengan's aim of strengthening their leading market position in China, while the well proven Advantage DCT Technology ensures a stable production of high-quality tissue, in this case mainly used for facial, toilet and towel grades.
Hengan is China's leading tissue producer, with a current tissue production exceeding one million tonnes per year. The high-performance Advantage DCT 200 trio counts for an annual capacity of least 180,000 tonnes of tissue products, soon to be 240,000 tonnes once all four production lines are started and optimised.
Valmet's delivery comprises four Advantage DCT 200 tissue production lines, featuring automation, stock preparation systems and the well-proven Advantage technology including OptiFlo headbox, Yankee, AirCap hood, WetDust dust system and SoftReel reel.
Hengan International Group Company is an investment holding company mainly engaged in the trading of personal hygienic products. Valmet is the leading global developer and supplier of process technologies, automation and services for pulp, paper and energy industries. (SV)